Passer au contenu

/ Research

Je donne


Health Sciences; Medical Sciences

Samir Jabbour

Cornée, segment antérieur, et chirurgie réfractive.

Professeur adjoint de clinique

Faculté de médecine - Département d'ophtalmologie

Secondary number: 514 890-8000 (Travail 1)
Secondary emails: (Travail) (Personnel)


Research expertise

Dr Jabbour est ophtalmologiste clinicien-chercheur sous-spécialisé dans la gestion des maladies complexes du segment antérieur, les greffes de cornée et la reconstruction de la surface oculaire, incluant les greffes de cellules souches limbiques. Ses intérêts de recherche comprennent la gestion des maladies de la surface oculaire, ainsi que les techniques chirurgicales en kératoplastie, en cataracte et en chirurgie réfractive. Il a aussi un intérêt en santé publique dans lequel il complète une maîtrise avec une sous-spécialisation en épidémiologie et biostatistique.


  • 2022-présent Master in Public Health (MPH) - Harvard University, Boston, MA
  • 2021-présent Professeur adjoint de clinique - Université de Montréal, Montréal, QC
  • 2020-2021 Fellowship clinique en cornée, segment antérieur et chirurgie réfractive / Moorfields Eye Hospital NHS Foundation Trust, Londres, Royaume-Uni
  • 2020 American Board of Ophthalmology (ABO), U.S.A.
  • 2019-2020 Fellowship clinique en cornée, segment antérieur et chirurgie réfractive / Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, MD
  • 2019 Collège Royal des Médecins et Chirurgiens du Canada (FRCSC) en Ophtalmologie
  • 2016 Licence en Médecine du Collège Canadien (LMCC)
  • 2016 National Board of Medical Examination U.S.A. (NBME)
  • 2014-2019 Diplôme d’études spécialisées, Résidence en ophtalmologie / Université de Montréal, Montréal, QC
  • 2010-2014 M.D.C.M. / Université McGill, Montréal, QC
  • 2007-2010 B.Sc. (Physiologie) / Université McGill, Montréal, QC
  • 2007 Baccalauréat Français Scientifique, Normandie, France

Awards and recognitions

Bourses de formation obtenues

  • 2012 Bourse Clarke McLeod (5000$), Université McGill, Québec
  • 2007 Bourse de l’Académie de Caen (6000 €), Normandie, France

Prix obtenus pendant la formation

  • 2017 Sélection à Résident Chef, Université de Montréal, Montréal, Québec
  • 2013 Sélection à « Physicianship Apprentice », Université McGill, Montréal, Québec
  • 2010 Liste d’honneur du doyen, Université McGill, Montréal, Québec
  • 2010 Sélection à Chargé de cours (Mammlian Physiology II), Université McGill, Montréal, Québec
  • 2010 Sociéte Golden Key Academic Honor, Montréal, Québec

Affiliations and responsabilities

Research affiliations

Research units


Affiliated institutions

  • Centre hospitalier de l’Université de Montréal (CHUM)

University service and activities

Administrative responsibilities

Directeur de monitorat clinique - cornée et segment antérieur (CHUM)

Teaching and supervision



Publications and presentations


Phylactou M, Jabbour S, Ahmad S, Avsquez-Perez A* (2021). Corneal perforation in patients under treatment with dupilumab for atopic dermatitis. Cornea 2021, published ahead of print

Jabbour S, Phyactou M, Ahmad S* (2021). Ocular mucous membrane pemphigoid: novel treatment strategies. Curr Opin Allergy Clin Immunol, published ahead of print

Jabbour S, Bower KS* (2021). Refractive Surgery in the US in 2021. JAMA 2021; 326:77-78

Akpek EK*, Karakus S, Yohannan J, Jabbour S, Sotimehin AE, LI G, Ramulu PY (2021). Reliability of Several Glaucoma Tests in Patients with Boston Type 1 Keratoprosthesis. Cornea, published ahead of print

Jabbour S, Din N, Logeswaran A, Sanchez ST, Ahmad S* (2021). Clinical Characteristics of Patients with Chronic Stevens-Johnson Syndrome Treated at a Major Tertiary Eye Hospital Within the United Kingdom. Front Med (Lausanne) 2021; 8:644795

Jabbour S*, Bower KS (2021). Three-year Outcomes of Implantable Collamer Lens Followed by Excimer Laser Enhancement (“Bioptics”) in the Treatment of High Myopic Astigmatism. Clin Ophthalmol 2021; 15:635-643

Ansah D, Wang J, Lu K, Jabbour S, Bower KS, Soiberman U* (2020). Post-FDA approval results of epithelium-off, full-fluence, Dresden protocol corneal collagen cross-linking in the USA. Ophthalmol Ther 2020; 9:1023-1040

Jabbour S, Jun AS, Shekhawat NS, Woreta FA, Krick T, Srikumaran D* (2020). Descemet Membrane Endothelial Keratoplasty (DMEK) Using a Pull-Through Technique with Novel Infusion Forceps. Cornea 2020; 40:387-292.

Jabbour S*, Shekhawat NS, Chen A, Akpek EK, Woreta FA (2020). Herpes zoster ophthalmicus reactivation following Shingrix vaccination. Cornea 2020; 40:248-250

Jabbour S*, Hamel P, Soucy JP, Ospina LH (2020). Allgrove syndrome: a report of new pathological mutations in the AAAS gene. Cornea 2020; 39:782-783

Jabbour S*, Choremis J, Boutin T, Brunette I, Mabon M, Talajic J (2019). Poor long-term outcomes of keratopigmentation with black ink for the treatment of dysphotopsia secondary to laser peripheral iridotomies. Cornea 2019; 38:1400–1405

Jabbour S*, Harissi-Dagher M, Agoumi Y, Singh H, Robert MC (2019) Outcomes of cyclophotocoagulation in the control of glaucoma in patients with the Boston Keratoprosthesis type 1. Cornea 2019;  39:181–185.

Jabbour S*, Talajic J, Mabon M, Modabber M, Choremis J (2019) Descemet membrane endothelial keratoplasty for epithelial downgrowth after cataract surgery. Can J Ophthalmol 2019;  54:e151-e153

Modabber M, Talajic J, Mabon M, Mercier M, Jabbour S, Choremis J* (2018). The role of novel DMEK graft shapes in facilitating intraoperative unscrolling. Graedes Arch Clin Exp Ophthalmol 2018; 256:2385-2390

Jabbour S*, Lesk M, Harissi-Dagher M (2018). Patch graft using collagen matrix (Ologen) for glaucoma drainage device exposure in a patient with the Boston Keratoprosthesis type 1. Am J Ophthalmol Case Rep 2018; 12:32-35

Fung SS*, Jabbour S, Harissi-Dagher M, Tan RR, Hamel P, Baig K, Ali A (2017). Visual outcomes and complications of type I Boston keratoprosthesis in children: a retrospective multicenter study and literature review. Ophthalmology 2017; 125:153-160

Jabbour S*, Muzychuk A, Agoumi, Harissi-Dagher M (2017). An unusual case of acute angle-closure glaucoma following deep anterior lamellar keratoplasty using the “big bubble” technique. Am J Ophthalmol Case Rep 2017; 7:126-128

Jabbour S*, Harissi-Dagher M (2017). Plugging the gap: Could frozen Boston Keratoprosthesis grafts end the cornea donor shortage? Expert Review of Ophthalmology 2017; 12:421-427

Jabbour S, Harissi-Dagher M. (2016). Recessive mutation in a nuclear-encoded mitochondrial tRNA synthetase associated with infantile cataract, congenital neurotrophic keratitis, and orbital myopathy. Cornea, 35(6), 894-896.

Haque M, Jabbour S, Fadlallah A, Harissi-Dagher M, Chelala E, Melki S* (2016). Integrity of intrastromal arcuate keratotomies performed by femtosecond laser. J Refract Surg 2016; 32:67-68

Zoroquiain P*, Jabbour S, Aldrees S, Villa N, Bravo-Filho V, Dietrich H., Burnier MN (2016). High frequency of squamous intraepithelial neoplasia in pterygium related to low ultraviolet light exposure. Saudi J Ophthalmol 2016; 30;113-116

Boutin T*, Jabbour S, Harissi-Dagher M (2015). Improving management and outcomes of the Boston type 1 keratoprosthesis: lessons learned from available evidence. Expert Review of Ophthalmology 2015; 10:229-239

Zoroquiain P*, Logan P, Bravo-Filho V, Vila N, Jabbour S, Orellana ME, Burnier MN (2015). Diagnosing Pathological Prognostic Factors in Retinoblastoma: Correlation between Traditional Microscopy and Digital Slides. Ocul Oncol Pathol 2015; 1:259-265

Jamal MH*, Hassanain M, Chaudhury P, Tran TT, Wong S, Yousef Y, Jozaghi Y, Salman A, Jabbour S, Simoneau E, Al‐Abbad S (2012). Staged hepatectomy for bilobar colorectal hepatic metastases. HPB 2012; 14:782-789.


  • Ophthalmology

Areas of expertise

  • Transplantation and Graft Rejection
  • Eye and Visual System Diseases
  • Neuronal Transplantation and Stem Cells
  • Visual System
  • Vision